0001140361-18-012140.txt : 20180305
0001140361-18-012140.hdr.sgml : 20180305
20180305215934
ACCESSION NUMBER: 0001140361-18-012140
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KURIYEL RALF
CENTRAL INDEX KEY: 0001733143
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 18668552
MAIL ADDRESS:
STREET 1: 41 SEYON ST
STREET 2: BLDG 1, STE. 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
3
1
doc1.xml
FORM 3
X0206
3
2018-02-28
0
0000730272
REPLIGEN CORP
RGEN
0001733143
KURIYEL RALF
C/O REPLIGEN CORPORATION
41 SEYON ST, BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Senior VP, R&D
Common Stock
5962
D
Stock Option (Right to Buy)
33.05
2026-12-14
Common Stock
10000
D
This option shall vest as follows: 2,000 shares shall vest on 12/14/2017; 12/14/2018; 12/14/2019; 12/14/2020 and on 12/14/2021.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2018-03-05